Citizens reiterates Market Outperform rating on Blend Labs stock ahead of Q3 results

Investing.com - Citizens has reiterated its Market Outperform rating and $7.00 price target on Blend Labs (NYSE:BLND), representing over 100% upside from the current price of $3.37, ahead of the company’s third-quarter 2025 earnings report. The $874 million market cap company has received a "GOOD" Financial Health score according to InvestingPro analysis.

The financial services company maintained its positive outlook on the mortgage technology provider before Blend Labs reports its quarterly results on Thursday, November 6, after market close. InvestingPro data reveals the company holds more cash than debt on its balance sheet, with analysts predicting a return to profitability this year despite an expected sales decline.

Citizens noted "a number of other interesting developments" surrounding Blend Labs in its research note, though specific details about these developments were not provided.

The firm’s maintained rating comes as Blend Labs stock has decreased 20% year-to-date, underperforming compared to the Russell 3000 index, which has increased 13% during the same period.

The current $7.00 price target from Citizens represents potential upside for Blend Labs shares from their current trading level, following the significant year-to-date decline.

In other recent news, Blend Labs has seen an increase in investment from Haveli Investments, as reported by Keefe, Bruyette & Woods (KBW). This development follows KBW’s decision to maintain its Market Perform rating on the company. The investment firm also reaffirmed its price target of $3.75 for Blend Labs. These updates reflect the latest activities surrounding Blend Labs and highlight the ongoing interest from investors. Such moves are often closely monitored by market participants for potential impacts on the company’s future performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.